Evidence map›Paper›PMID 41911099›Full record

ReviewNeuroimmunomodulation2026

Interactions between Innate Immune Memory and the Central Nervous System.

Rafaela Rodrigues Valerio, Andressa Bernardi, Adriana Bonomo, Rudimar Luiz Frozza

Abstract readReview
In one paragraph

Review in Neuroimmunomodulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rafaela Rodrigues ValerioLaboratory on Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro, Brazil.
Andressa BernardiLaboratory of Inflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro, Brazil.
Adriana BonomoLaboratory on Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro, Brazil.
Rudimar Luiz FrozzaLaboratory on Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro, Brazil, rudimar.frozza@ioc.fiocruz.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTraditionally, immunology has assumed the dogma that immunological memory is exclusive to cells of the adaptive immune system. However, over the past decade, evidence has challenged this paradigm by demonstrating that innate immune cells can exhibit adaptive characteristics, resulting in long-term functional changes. After exposure to infections or sterile inflammation, innate immune cells can exhibit either an enhanced or suppressed inflammatory response upon secondary challenge. This de facto immune memory has been termed trained immunity or immune tolerance, respectively. SUMMARY: This review outlines both classical and newly described features of innate immune cells, highlighting the concepts of trained immunity and innate tolerance, along with their underlying molecular mechanisms. We also discuss the implications of innate immune memory in microglia and explore the potential therapeutic approaches for manipulating innate immunity in the context of neurodegenerative disorders. KEY MESSAGES: While trained immunity plays a crucial role in protecting the host against infections, its dysregulation can lead to chronic inflammation, autoimmune diseases, and potentially contribute to the development of neurodegenerative disorders. On the other hand, tolerance can reduce the inflammatory response and promote tissue regeneration but can also result in increased susceptibility to secondary infections. The long lifespan of microglia, coupled with their ability to learn and adapt their response to previously encountered pathogens or stimuli, underscores the potential long-term implications of their innate immune memory for the development of neuropathology.

Indexed as

Central Nervous SystemImmune ToleranceImmunologic MemoryTrained ImmunityAnimalsHumansMicrogliaNeurodegenerative DiseasesCentral nervous systemInnate immunityMicrogliaToleranceTrained immunity

Identifiers

PMID41911099
PMCPMC13245947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.